Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1378710 | Bioorganic & Medicinal Chemistry Letters | 2006 | 4 Pages |
A series of new camptothecin derivatives, as topoisomerase I inhibitor, were synthesized to identify potent antitumor agents. The synthesis method was based on the Claisen rearrangement of 10-allyloxy-7-ethylcamptothecin. All of the compounds were assayed for cytotoxicity against two human tumor cell lines, Bel7402, HCT116, and showed good potency in vitro. Compounds 2, 4, 9, were assessed for the stability of lactone in human plasma. And then compound 2 was tested for antitumor activity in vitro against mouse tumor sarcoma-180. The results suggested that the small alkyl groups in the both 7- and 9-positions of camptothecin could promote liposolubility, antitumor activity in vitro and vivo, though did not bring much increase of the stability of lactone.
Graphical abstract7-Ethyl-9-alkyl derivatives of camptothecin were synthesized and tested for antitumor activity in vitro and in vivo, and evaluated for the stability of lactone ring.Figure optionsDownload full-size imageDownload as PowerPoint slide